XTLB - Prakiraan volume dodolan XTL Biopharmaceuticals

Lambang korporat lan logo XTL Biopharmaceuticals Ltd (XTLB)

XTL Biopharmaceuticals (XTLB) maintains a flexible, asset-light structure based on external manufacturing and outsourced testing. The company's expected sales dynamics are clearly illustrated in GURU.Markets, where the 0.00 mark serves as the current indicator. The brand possesses significant scientific weight in the licensing of autoimmune pathology therapies, and its current strategic vector is focused on pursuing M&A deals to achieve a complete pivot of its business model.

xtlbio.com - Prakiraan pendapatan perusahaan XTLB (periode 04.07.2022 - 16.11.2026)

Rincian analitis perusahaan XTL Biopharmaceuticals (XTLB)

Pambiji fundamental:XTL Biopharmaceuticals Ltd.
Produk mawa merek XTL Bio

The scale of operations at XTL Biopharmaceuticals (XTLB) correlates directly with the dynamics of the firm's future sales proceeds. This metric measures market revenue expectations, filtering the issuer by its commercial development trajectory. The calculation is based on analyst consensus forecasts, reflecting the probability of realizing new biopharmaceutical assets. For a company facing a capital deficit, a decline in this indicator signals rising credit risks. A decrease in these metrics confirms difficulties in stabilizing positions without resorting to price dumping.

Perusahaan pesaing

Prakiraan pendapatan perusahaan Argenx (ARGX)|BioNTech - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan ABVX (Abivax)|ADMA Bio (ADMA) - Volume dodolan sing dikarepake perusahaan|PTGX - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan immunovant.com IMVT|KNSA: Prakiraan volume dodolan|Grifols - Pendapatan mangsa ngarep perusahaan|ADPT (Adaptive Biotech) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan CLDX|Prakiraan volume dodolan AUPH|Volume dodolan mangsa ngarep perusahaan biocryst.com BCRX|Vera Therapeutics - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV - Prakiraan volume dodolan|ABCL: Prakiraan pendapatan perusahaan|Tourmaline Bio, Inc. (TRML) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan precigen.com (PGEN)|PHAR (pharming.com) - Prakiraan volume dodolan|NKTR (Nektar Therapeutics Inc.) - Prakiraan volume pendapatan perusahaan|Prakiraan volume dodolan UPB|ZBIO - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan IMNM (immunome.com)|Gossamer Bio, Inc. - Prakiraan pendapatan perusahaan|KalVista Pharmaceuticals, Inc. - Prakiraan volume dodolan|SEPN (Septerna) - Prakiraan pendapatan perusahaan|Pieris Corp (PVLA) - Prakiraan pendapatan perusahaan|SVRA - Dodolan mangsa ngarep perusahaan|RIGL (rigel.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ANAB (AnaptysBio, Inc.)|Prakiraan volume dodolan ATXS|enGene Holdings Inc (ENGN) - Prakiraan dodolan perusahaan|Prakiraan volume dodolan RAPT (RAPT Therapeutics Inc.)|JBIO (Aerovate) - Pendapatan sing dikarepake perusahaan|ACRS: Volume dodolan mangsa ngarep perusahaan|KYTX - Prakiraan volume dodolan|TLSA: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cabaletta Bio, Inc|Prakiraan pendapatan perusahaan Ventyx Biosciences, Inc|THTX: Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan AVTX (Avalo Therapeutics, Inc)|Volume dodolan mangsa ngarep perusahaan Eledon Pharmaceuticals ELDN|Prakiraan pendapatan perusahaan Agenus, Inc. AGEN|Prakiraan volume dodolan Climb Bio Inc. CLYM|ZURA - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan ATYR|ADAG (Adagene Inc.) - Volume dodolan mangsa ngarep perusahaan|ImageneBio Inc (IMA) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Shattuck Therapeutics|Volume dodolan mangsa ngarep perusahaan equilliumbio.com (EQ)|Prakiraan volume dodolan CNTB|Dodolan mangsa ngarep perusahaan Immunic Therapeutics|Prakiraan volume dodolan ATRA (Atara Biotherapeutics, Inc.)|IFRX - Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Prakiraan pendapatan perusahaan|CELU: Prakiraan volume dodolan|INMB - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Barinthus Biotherapeutics plc|KZR: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan SABS|AKTX (Akari Therapeutics Plc) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Prakiraan pendapatan perusahaan|GOVX: Volume dodolan mangsa ngarep perusahaan|edesabiotech.com (EDSA) - Volume dodolan mangsa ngarep perusahaan|IBIO: Prakiraan volume dodolan|CARM - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan boltbio.com|Prakiraan volume dodolan hcwbiologics.com|Volume dodolan mangsa ngarep perusahaan APVO (aptevotherapeutics.com)|Dodolan mangsa ngarep perusahaan AIM ImmunoTech, Inc.|Prakiraan volume dodolan ADTX (Aditxt)|Pendapatan mangsa ngarep perusahaan GRI|XRTX - Prakiraan pendapatan perusahaan|HIND: Prakiraan pendapatan perusahaan|REVB (Revelation Biosciences Corp) - Volume dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan INDP|Prakiraan pendapatan perusahaan Scinai Immunotherapeutics Ltd|calcimedica.com (CALI) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Affimed NV (AFMD)|Allakos - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan HOOKIPA Pharma, Inc. HOOK|IGMS - Volume dodolan mangsa ngarep perusahaan|ITOS: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Ocean Biomedical|TCBP: Prakiraan volume dodolan|Third Harmonic Bio, Inc - Pendapatan mangsa ngarep perusahaan